10 insiders reported 20 Form 4 transactions for Prelude Therapeutics Inc (PRLD) over the past 18 months (most recent 2026-04-28). Recent activity: Shah Rajeev M. (10% Owner) Sell 1.4M shares, RA CAPITAL MANAGEMENT, L.P. (10% Owner) Sell 1.4M shares, Kolchinsky Peter (10% Owner) Sell 1.4M shares, RA Capital Healthcare Fund LP (10% Owner) Sell 1.4M shares, ORBIMED ADVISORS LLC (Director) Buy 1.7M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-28 | Shah Rajeev M. | 10% Owner | Sell | 1.4M | $0 |
| 2026-04-28 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 1.4M | $0 |
| 2026-04-28 | Kolchinsky Peter | 10% Owner | Sell | 1.4M | $0 |
| 2026-04-28 | RA Capital Healthcare Fund LP | 10% Owner | Sell | 1.4M | $0 |
| 2026-04-23 | ORBIMED ADVISORS LLC | Director | Buy | 1.7M | $7.5M |
| 2026-04-23 | ORBIMED CAPITAL LLC | Director | Buy | 1.7M | $7.5M |
| 2026-04-23 | OrbiMed Capital GP VI LLC | Director | Buy | 1.7M | $7.5M |
| 2026-04-23 | OrbiMed Genesis GP LLC | Director | Buy | 1.7M | $7.5M |
| 2026-04-23 | ORBIMED ADVISORS LLC | Director | Buy | 1.1M | $5.0M |
| 2026-04-23 | ORBIMED CAPITAL LLC | Director | Buy | 1.1M | $5.0M |
| 2026-04-23 | OrbiMed Capital GP VI LLC | Director | Buy | 1.1M | $5.0M |
| 2026-04-23 | OrbiMed Genesis GP LLC | Director | Buy | 1.1M | $5.0M |
| 2026-04-23 | Bonita David P | Director | Buy | 1.7M | $7.5M |
| 2026-04-23 | Bonita David P | Director | Buy | 1.1M | $5.0M |
| 2025-10-07 | Huang Jane | President, CMO | Buy | 9,375 | $0 |
| 2025-10-07 | Huang Jane | President, CMO | Sell | 3,355 | $4,932 |
| 2025-07-08 | Huang Jane | President, CMO | Buy | 9,375 | $0 |
| 2025-07-08 | Huang Jane | President, CMO | Sell | 3,355 | $2,650 |
| 2025-04-07 | Huang Jane | President, CMO | Buy | 9,375 | $0 |
| 2025-04-07 | Huang Jane | President, CMO | Sell | 3,355 | $2,281 |
来源：SEC Form 4 申报文件 · 截至 2026-04-28